Greylin Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$62.6M |
| 2 |
NXP Semiconductors
NXPI
|
+$18.3M |
| 3 |
SLB Ltd
SLB
|
+$15M |
| 4 |
United Therapeutics
UTHR
|
+$14M |
| 5 |
Kraft Heinz
KHC
|
+$6.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$9.56M |
| 2 |
Gilead Sciences
GILD
|
+$9.19M |
| 3 |
USG
Usg
USG
|
+$4.21M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$2.7M |
| 5 |
IBM
IBM
|
+$2.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.81% |
| 2 | Energy | 20.1% |
| 3 | Technology | 14.87% |
| 4 | Healthcare | 11.77% |
| 5 | Consumer Staples | 7.6% |
Similar funds
Greylin Investment Management's Q4 2018 Portfolio in Review
As of Q4 2018, Greylin Investment Management held 87 positions worth $417M, down 10% from $464M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Greylin Investment Management deployed $82.1M of net new capital in Q4 2018, opening 11 new positions and adding to 13 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 200 shares worth $612K.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 37% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Merck, an estimated $9.56M trimmed.
- Greylin Investment Management's largest Q4 2018 buy was Berkshire Hathaway Class A: 200 shares worth $612K.
- Greylin Investment Management added most to SLB Ltd in Q4 2018, an estimated $15M increase.
- Greylin Investment Management's biggest Q4 2018 reduction was Merck, cutting an estimated $9.56M.
- Greylin Investment Management fully exited Meridian Bioscience Inc in Q4 2018, selling an estimated $709K.
- Greylin Investment Management's ten largest holdings make up 71% of its $417M portfolio in Q4 2018.
- Greylin Investment Management opened 11 new positions and closed 12 in Q4 2018.
- Greylin Investment Management's portfolio value fell 10% quarter-over-quarter to $417M.
Based on Greylin Investment Management's 13F filing for Q4 2018, filed 14 Jan 2019.